Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

129
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
129
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

185
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
185
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

182
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
182
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.0K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.0K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

73
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
73
Fundamental Mathematical Principles in Pharmacokinetics: Mathematical Expressions and Units01:19

Fundamental Mathematical Principles in Pharmacokinetics: Mathematical Expressions and Units

771
Mathematical principles play a crucial role in pharmacokinetics, providing a framework for understanding and quantifying drug distribution and elimination dynamics in the body. By utilizing mathematical expressions and units, pharmacologists can accurately characterize the behavior of drugs, optimize dosing regimens, and predict therapeutic outcomes.
One significant application of mathematics in pharmacokinetics is the characterization of drug distribution through the volume of distribution...
771

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Shared and culture-specific brain networks for emotional facial discrimination: Evidence from predictive modeling.

Neuropsychologia·2026
Same author

A self-perpetuating neuron-intrinsic GSDMD-mtDNA-AIM2 inflammasome axis drives neuronal pyroptosis and cognitive impairment after traumatic brain injury.

Frontiers in immunology·2026
Same author

The timing of visual selective attention in fronto-parietal network: TMS behavioral and brain structural evidence.

Neuroscience·2026
Same author

The role of inferior frontal gyrus in emotion regulation: Evidence from fMRI and tDCS investigation.

International journal of psychophysiology : official journal of the International Organization of Psychophysiology·2026
Same author

Modeling and Simulation of Mass Transfer in Food Processing: Recent Advances in Governing Equations, Workflow, and Applications.

Foods (Basel, Switzerland)·2026
Same author

Electrodeposited Ni<sub>3</sub>Fe alloy on carbon cloth for efficient oxygen evolution.

Chemical communications (Cambridge, England)·2026

相关实验视频

Updated: Jul 15, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

798

图表正规化非负矩阵因子化与规范正规化术语的药物向相互作用的预测.

Junjun Zhang1, Minzhu Xie1,2

  • 1Key Laboratory of Computing and Stochastic Mathematics(LCSM) (Ministry of Education), School of Mathematics and Statistics, Hunan Normal University, Changsha, 410081 China.

BMC bioinformatics
|October 3, 2023
PubMed
概括

我们开发了iPALM-DLMF,这是一种用于预测药物向相互作用 (DTI) 的新型计算方法. 这种方法通过整合药物和目标相似性来提高准确性,并确保特征矩阵稀疏性,优于现有方法.

关键词:
药物目标相互作用惯性近接交替线性化最小化最小化美国的标准是NORM.

更多相关视频

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.4K

相关实验视频

Last Updated: Jul 15, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

798
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.4K

科学领域:

  • 生物信息学是一种生物信息学.
  • 计算机化药物发现技术
  • 化学信息学 化学信息学

背景情况:

  • 确定药物向相互作用 (DTI) 对药物开发至关重要.
  • 用于DTI识别的湿实验是资源密集的.
  • 计算方法加速药物发现,但往往忽视特征稀疏性和算法融合.

研究的目的:

  • 提出一个准确的计算方法来预测DTI.
  • 为了解决DTI预测现有的非负矩阵因数分解方法的局限性.

主要方法:

  • 开发了iPALM-DLMF,这是一种使用非负矩阵因数分解进行DTI预测的新方法.
  • 嵌入式图表双重规范化用于药物和目标相似性集成.
  • 使用L1规范规范化来实现特征矩阵稀疏性.
  • 采用惯性近接交替线性最小化来实现模型的融合.

主要成果:

  • 与最先进的方法相比,iPALM-DLMF表现出更高的性能.
  • 案例研究显示了高的验证率:46/50对于 gabapentin 标和47/50对于前列腺素-内氧化合成酶2标.
  • 该方法有效地整合了相似性信息,并确保了特征稀疏性.

结论:

  • iPALM-DLMF提供了一种更准确,更有效的方法来预测DTI.
  • 该方法的收特性和规范化技术增强了预测能力.
  • 这种计算工具可以大大帮助加快药物发现过程.